UnitedHealth Stock Could Reach New Heights by 2030: Here’s the Outlook

Core Viewpoint - The outlook for UnitedHealth (NYSE:UNH) stock is uncertain, but the decline in stock price may present a multi-year investment opportunity due to the increasing demand for healthcare services from the aging baby boomer population [2][3]. Group 1: Stock Performance and Valuation - UnitedHealth's stock has decreased by 47% over the past 12 months, indicating a significant drop in value [4]. - The current trailing 12-month (TTM) price-to-earnings (P/E) ratio for UnitedHealth is 17.51x, which is 17.34% lower than its five-year average [5]. - The TTM price-to-sales (P/S) ratio stands at 0.58x, representing a 55.22% decline from the five-year average, suggesting potential undervaluation [6]. Group 2: Investment Considerations - The current low valuation may attract contrarian investors who believe that the known challenges are already reflected in the stock price, potentially leading to a rebound by 2030 [3]. - Despite concerns about being a "value trap," long-term shareholders can benefit from a forward annual dividend yield of 3.1% [6]. - UnitedHealth's full-year 2025 revenue is projected to grow by 12% year over year, indicating positive financial performance despite recent stock price challenges [8].